Recent Article from Sharecafe: Genetic Signatures Leverages New Screening Targets to EU and US Markets
A recent article published via Sharecafe discusses Genetic Signatures’ new syndromic EasyScreen™ targets for use in EU and US Markets. To read more Click link
Read MoreGenetic Signatures’ CEO Dr John Melki will be presenting ShareCafe Micro/Small Cap “Hidden Gems” webinar
Genetic Signatures’ CEO Dr John Melki will be presenting ShareCafe Micro/Small Cap “Hidden Gems” webinar to be held at 12.30 pm AEST on Friday, 12 February 2021. The webinar is free to join and participants are required to register in advance via the following link: https://us02web.zoom.us/webinar/register/WN_KHst7HftQdSiQwoL6y9ufg
Read MoreGenetic Signatures (ASX: GSS) Annual Report 2020
Genetic Signatures Annual Report 2020 released. Click link for more information.
Read MoreWatch ShareCafe’s Hidden Gems Webinar
Genetic Signatures’ CEO Dr John Melki presenting at ShareCafe webinar
Genetic Signatures’ CEO Dr John Melki will be presenting ShareCafe Micro/Small Cap “Hidden Gems” webinar to be held at 12.30 pm AEST on Friday, 28 August 2020. The webinar is free to join and participants are required to register in advance via the following link: https://us02web.zoom.us/webinar/register/WN_Mjb04hQtSY-nlSbLqWlpSw
Read MoreGenetic Signatures (ASX: GSS) Investor Presentation
Genetic Signatures latest Investor Presentation released. Click link for more information.
Read MoreGenetic Signatures (ASX: GSS) latest Investor Presentation
Genetic Signatures latest Investor Presentation released. Click link for more information.
Read MoreGenetic Signatures latest Investor Presentation
Genetic Signatures latest Investor Presentation released. Click link for more information.
Read MoreGenetic Signatures’ CEO Dr. John Melki in Australia’s Sydney Morning Herald discussing how our technology is helping diagnose COVID-19 patients
A recent article published in Australia’s Sydney Morning Herald with Genetic Signatures’ CEO Dr. John Melki discusses how our novel 3baseTM technology utilised in our EasyScreenTM SARS-CoV-2 Detection Kit has assisted in the quick diagnosis of the virus amongst patients. For more on the article click link “It is ultimately saving lives’: Businesses respond to…
Read MoreGenetic Signatures’ COVID-19 test highlighted in Australia’s recent Sydney Morning Herald
A recent article published in Australia’s Sydney Morning Herald highlights the importance of nationwide screening for COVID-19 testing. For more on the article click link Inside a COVID-19 lab and why more people return inconclusive tests
Read More